KIMBERLY BROWN: Open Payments
NPI 1205943859 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,884 in 40 payments from 6 companies in 2025. Trend: 2023 $3,954 · 2024 $1,157 · 2025 $3,884
Consulting: $2,570Food & beverage: $1,179Travel & lodging: $135
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $2,080 |
| UCB, Inc. | 8 | $1,341 |
| ABBVIE INC. | 11 | $202 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Arcutis Biotherapeutics, Inc. | 1 | $120 |
| Avanos Medical | 1 | $18 |
Products named: COSENTYX, Bimzelx, SKYRIZI, Rhapsido, TREMFYA, Zoryve, RINVOQ, ON-Q PUMP AND ACCESSORIES.
Industry payments across MO — which companies pay providers there.
